A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants

Clinical trial NCT07254728 · COMPLETED

Trial details

NCT number: NCT07254728
Sponsor: Vaxart
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Norovirus Infections

Start date: 2023-10-27
Primary completion: 2024-12-13
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.